(lp0
S'Ronin Capital, Llc is Buying Peregrine Pharmaceuticals Inc.... Small Cap Exclusive  - 6 hours ago In a just published Form 13, filed with the US Securities and Exchange Commission , Peregrine Pharmaceuticals Inc.  reported that Ronin Capital, Llc.Peregrine Pharmaceuticals, Inc. Posted losses of -2.18% in the Last Trade - Free ObserverBuy or Sell? Average Brokerage Ratings on Sterling Bancorp , Peregrine ... - StockNewsJournal'
p1
aS'BRIEF-Ronin Capital LLC reports 5.8 pct stake in Peregrine Pharmaceuticals Reuters - 15 hours ago BRIEF-Ronin Capital LLC reports 5.8 pct stake in Peregrine Pharmaceuticals. April 17 Peregrine Pharmaceuticals Inc. * Ronin Capital LLC reports 5.8 percent stake in Peregrine Pharmaceuticals Inc as of April 6 - sec filing Source text : bit.ly/2prmM8N ...'
p2
aS'Peregrine Pharmaceuticals Announces Five Abstracts Accepted for Presentation ... GlobeNewswire  - Mar 23, 2017 TUSTIN, Calif., March 23, 2017  -- Peregrine Pharmaceuticals, Inc.  , a biopharmaceutical company committed to improving patient lives by manufacturing high quality products for biotechnology and&nbsp;...'
p3
aS'Peregrine Pharmaceuticals Highlights Clinical Data Presentation at AACR 2017 ... Yahoo Finance - Apr 4, 2017 TUSTIN, Calif., April 04, 2017  -- Peregrine Pharmaceuticals, Inc.  , a biopharmaceutical company committed to improving patient lives by manufacturing high quality products for biotechnology and pharmaceutical&nbsp;...Peregrine Pharmaceuticals  Receiving Somewhat Positive News Coverage ... - The Cerbat Gem'
p4
aS'Peregrine Pharma  Announces Presentation of Preclinical Study Results ... StreetInsider.com - Apr 3, 2017 Peregrine Pharmaceuticals, Inc.  , a biopharmaceutical company committed to improving patient lives by manufacturing high quality products for biotechnology and pharmaceutical companies and advancing its&nbsp;...'
p5
aS'PEREGRINE PHARMACEUTICALS, INC.  Files An 8-K Notice of Delisting ... Market Exclusive - Apr 12, 2017 PEREGRINE PHARMACEUTICALS, INC.  Files An 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.'
p6
aS'Market Sentiment Improving on Peregrine Pharmaceuticals  The Oracle Dispatch - Apr 8, 2017 Peregrine Pharmaceuticals  shares started the 2017 rally right before Valentines Day, with a high volume move taking shares from .32 cents to .55 cents, and continued higher into the end of Q1 and currently sit +107% for the year as an&nbsp;...Peregrine Pharmaceuticals  Earns Daily Media Sentiment Rating of 0.36 - Chaffey Breeze'
p7
aS'Experts proposition on the searing stocks: Peregrine Pharmaceuticals, Inc ... The USA Commerce - 21 hours ago On the close of 04/13/2017 Peregrine Pharmaceuticals, Inc.  dropped -2.18% to hit $0.54. During the session shares stayed in the range from $0.548 to $0.481.'
p8
aS"Biotech Industry Continues to Provide Investors with Gains in 2017: Today's ... Yahoo Finance - Mar 27, 2017 NEW YORK, NY / ACCESSWIRE / March 27, 2017 / Peregrine Pharmaceuticals' shares might be trading below the dollar mark, but the upward trend has been promising."
p9
aS'Peregrine Pharmaceuticals, Inc.  Is Making A Strong Argument Through Its ... NY Stock News - Apr 12, 2017 The technicals for Peregrine Pharmaceuticals, Inc.  has spoken via its technical chart and the message is loud and clear.'
p10
a.